(Press-News.org) In a previous study, rheumatoid arthritis (RA) patients who failed to respond to methotrexate were shown to experience positive results with fostamatinib disodium (R788), an oral spleen tyrosine kinase (Syk) inhibitor that is thought to block immune cell signaling involved with bone and cartilage destruction. In the current study, RA patients who failed to respond to biologic agents were studied. In contrast to the prior study, however, fostamatinib was not effective in this group of patients, although the drug did appear to be safe. Results of this phase II trial are published in the February issue of Arthritis & Rheumatism, a journal of the American College of Rheumatology (ACR).
Patients with RA experience inflammation, pain and swelling of their joints that often limits daily activities and can lead to permanent disability. The National Arthritis Data Workgroup estimates that 1.3 million (0.6%) of adults in the U.S. have RA, affecting two to three times as many women as men. While many RA patients are successfully treated with disease-modifying anti-rheumatic drugs (DMARDs), those with moderate to severe RA may find that newer biologically-based therapies that inhibit cytokine activity, block T cell stimulation, or modify B cell biology slow disease progression, especially when combined with methotrexate (MTX). However, there remains a subgroup of the RA patient population who do not respond to DMARDs or current biologic therapies.
The three-month double-blind, placebo-controlled trial of R788, led by Mark Genovese, M.D., from Stanford University, enrolled 219 patients with active RA who failed to respond to one or more biologic therapies (TNF inhibitor, anakinra, abatacept, or rituximab). Patients were randomly assigned in a 2:1 ratio to receive 100 mg of R788 or placebo, respectively. Efficacy and safety were evaluated over three months. Researchers evaluated changes in the disease activity score (DAS); inflammation and joint damage were assessed by MRI.
"Our findings did not find an overall difference in efficacy between the small molecule drug, R788, and placebo," noted Dr. Genovese. "However, the drug was well tolerated and clinical benefit was found in only a subset of RA patients." Results showed that the primary outcome, the ACR 201 response, as well as the ACR 50 and 70 responses, were not significantly different between the group receiving R788 and the placebo group. However, in patients who entered the trial with an elevated C-reactive protein (CRP) level, analysis suggested a meaningful difference in the ACR 20 responses between the R788 (42%) and placebo (26%) groups. Additionally MRI results demonstrated improvement in joint inflammation in those patients with the greatest disease activity.
Researchers found that the 100mg dosage of R788 was well tolerated, with the most common adverse effects being nausea and diarrhea. "We found that 100mg of R788 was a tolerable dose for chronic administration in RA," concluded Dr. Genovese. "Phase III trials of R788 need to replicate our findings and identify subpopulations most likely to respond to this novel therapy."
INFORMATION:
1 The American College of Rheumatology provides a set of criteria (ACR 20, ACR 50, ACR 70) to use in clinical trials for rheumatoid arthritis that report the percentage of study participants who achieve improvement in tender or swollen joint counts. Therefore, the ACR 20 means that a 20 percent improvement in tender or swollen joint counts was achieved.
Article: "An Oral Syk Kinase Inhibitor in the Treatment of Rheumatoid Arthritis: A 3 Month Randomized Placebo Controlled Phase 2 Study in Patients with Active RA who had Failed Biologic Agents." Mark C. Genovese, Arthur Kavanaugh, Michael E. Weinblatt, Charles Peterfy, Julie DiCarlo, Michael L. White, Maryann O-Brien, Elliott B. Grossbard, and Daniel B. Magilavy. Arthritis & Rheumatism; Published Online: October 27, 2010 (DOI: 10.1002/art.30114); Print Issue Date: February 2011. http://onlinelibrary.wiley.com/doi/10.1002/art.30114/abstract.
This study is published in Arthritis & Rheumatism. Media wishing to receive a PDF of the article may contact healthnews@wiley.com.
About the Journal
Arthritis & Rheumatism is an official journal of the American College of Rheumatology (ACR) and the Association of Rheumatology Health Professionals (ARHP), a division of the College, and covers all aspects of inflammatory disease. The American College of Rheumatology (www.rheumatology.org) is the professional organization who share a dedication to healing, preventing disability, and curing the more than 100 types of arthritis and related disabling and sometimes fatal disorders of the joints, muscles, and bones. Members include practicing physicians, research scientists, nurses, physical and occupational therapists, psychologists, and social workers. For details, please visit http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1529-0131.
About Wiley-Blackwell
Wiley-Blackwell is the international scientific, technical, medical, and scholarly publishing business of John Wiley & Sons, with strengths in every major academic and professional field and partnerships with many of the world's leading societies. Wiley-Blackwell publishes nearly 1,500 peer-reviewed journals and 1,500+ new books annually in print and online, as well as databases, major reference works and laboratory protocols. For more information, please visit www.wileyblackwell.com or our new online platform, Wiley Online Library (wileyonlinelibrary.com), one of the world's most extensive multidisciplinary collections of online resources, covering life, health, social and physical sciences, and humanities.
Just touching it slightly with the tips of your fingers is enough. You can effortlessly write, navigate, open menu windows or rotate images on touchscreens. Within fractions of a second your touch is translated into control commands that a computer understands. At first glance, this technology borders on the miraculous, but in real life this mystery just is a wafer-thin electrode under the glass surface of the display made of indium-tin-oxide, ITO. This material is nothing short of ideal for use in touchscreens because it is excellent at conducting slight currents and lets ...
The baby and toddler phase is not necessarily the happiest time in life. Satisfaction with life and one's relationship can deteriorate for most new mothers. However, those who are satisfied with their relationship during pregnancy are most satisfied three years later.
This comes from a recent study from the Norwegian Institute of Public Health. The study includes 60,000 Norwegian women with small children.
"In this study we have investigated two types of satisfaction - satisfaction with the partner and general satisfaction with life - both during pregnancy and later ...
Researchers have proved that a single "master switch" enzyme, known as aldose reductase, is key in producing excess mucous that clogs the airways of people with asthma and chronic obstructive pulmonary disease (COPD). The enzyme's action can be blocked by drugs whose safety has been shown in clinical trials for other diseases – a discovery that could improve therapies for the 510 million people worldwide suffering from asthma and COPD.
The findings are from a University of Texas Medical Branch at Galveston study published in the online journal PLoS One.
Using ...
Although still rare, maternal deaths related to in vitro fertilisation (IVF) are a key indicator of risks to older women, those with multiple pregnancy and those with underlying disease, warn experts in an editorial published on bmj.com today.
Dr Susan Bewley and colleagues argue that serious adverse outcomes related to IVF treatment, such as ovarian hyperstimulation sydrome (a complication caused by some fertility drugs), should be systematically reported so that lessons can be learnt and appropriate action taken.
In 1991, the first published report of a maternal ...
Washington, DC, January 27, 2011 – Screening patients in the intensive care unit (ICU) for methicillin-resistant Staphylococcus aureus (MRSA) produces cost savings for the whole hospital, according to a study that used a statistical simulation model published in the February issue of the American Journal of Infection Control, the official publication of APIC - the Association for Professionals in Infection Control and Epidemiology.
Conducted by a team of researchers at the Minneapolis Veterans Affairs Medical Center, a 279-bed teaching hospital and outpatient facility, ...
Authored by Economics writer Romesh Vaitilingam, Recovery Britain: research evidence to underpin a productive, fair and sustainable return to growth examines some of the challenges the UK faces after the longest and deepest downturn since full records began. The report provides 20 key challenge areas and a number of policy solutions. It draws on analysis of a broad range of data sources and the work of numerous researchers and research institutions, including centres and programmes, funded by the ESRC.
The report also includes a foreword to the research findings by Professor ...
A new report by an Indiana University School of Dentistry department chair with researchers from six other U.S. dental schools is calling for quick and creative solutions to address the growing scarcity of full-time faculty members within the nation's dental school programs.
The report cites widening pay gaps between private practice dentists and clinical professors at dental schools as one factor in fewer dentists committing to careers in teaching. Clinical faculty also report being overwhelmed and burned out by the workload demands of teaching, clinical, research and ...
A new democracy barometer from the University of Zurich and the Social Science Research Center Berlin (WZB) shows the development of the thirty best democracies in the world. Den-mark, Finland and Belgium have the highest quality of democracy, whereas Great Britain, France, Poland, South Africa and Costa Rica the lowest. Moreover, the barometer shows no evidence of a crisis of democracy.
Diagnoses of a crisis of democracy are as old as democracy itself; they are a common theme in the political discourse of the Western world. However, until now there was no instrument ...
CHAPEL HILL, N.C. – Researchers at the University of North Carolina at Chapel Hill have pinpointed a crucial function for a key player in the development of the nervous system. They found that this player – a protein called Erk – is necessary for nerve fibers to be wrapped with an insulating substance called myelin, which allows messages to be sent from the brain to the peripheral limbs and back again.
The finding has particular importance because several neurodevelopmental disorders have recently been linked to genetic mutations in the complex developmental cascade ...
Scientists can now manufacture a synthetic version of the self-healing sticky substance that mussels use to anchor themselves to rocks in pounding ocean surf and surging tidal basins. A patent is pending on the substance, whose potential applications include use as an adhesive or coating for underwater machinery or in biomedical settings as a surgical adhesive or bonding agent for implants.
Inspiring the invention were the hair-thin holdfast fibers that mussels secrete to stick against rocks in lakes, rivers and oceans. "Everything amazingly just self-assembles underwater ...
